PRPH ProPhase Labs Inc
Price (delayed)
$0.3213
Market cap
$13.46M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.61
Enterprise value
$37.35M
ProPhase Labs is a diversified medical science and technology company with deep experience with OTC consumer healthcare products and dietary supplements. The Company is engaged in the research, development, manufacture,
Highlights
The company's gross margin has shrunk by 105% YoY but it has surged by 98% QoQ
PRPH's revenue has surged by 102% since the previous quarter but it has dropped by 81% year-on-year
The EPS has plunged by 166% YoY and by 69% from the previous quarter
The net income has dropped by 92% since the previous quarter
Key stats
What are the main financial stats of PRPH
Market
Valuations
Earnings
Shares outstanding
41.88M
Market cap
$13.46M
Enterprise value
$37.35M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.04
Price to sales (P/S)
0.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.52
Revenue
$6.77M
Gross profit
-$150,000
Operating income
-$38.63M
Net income
-$53.36M
EBIT
-$42.82M
EBITDA
-$36.18M
Free cash flow
-$18.22M
Per share
Balance sheet
Liquidity
EPS
-$2.61
EPS diluted
-$2.61
Free cash flow per share
-$0.89
Book value per share
$0.31
Revenue per share
$0.33
TBVPS
$2.36
Total assets
$63.2M
Total liabilities
$55.85M
Debt
$24.57M
Equity
$7.35M
Working capital
-$1.5M
Debt to equity
3.34
Current ratio
0.95
Quick ratio
0.65
Net debt/EBITDA
-0.66
Margins
Efficiency
Dividend
EBITDA margin
-534.3%
Gross margin
-2.2%
Net margin
-788.2%
Operating margin
-570.6%
Return on assets
-63%
Return on equity
-158.8%
Return on invested capital
-65.7%
Return on capital employed
-137.8%
Return on sales
-632.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PRPH stock price
How has the ProPhase Labs stock price performed over time
Intraday
3.58%
1 week
11.6%
1 month
4.05%
1 year
-93.44%
YTD
-57.56%
QTD
-20.53%
Financial performance
How have ProPhase Labs's revenue and profit performed over time
Revenue
$6.77M
Gross profit
-$150,000
Operating income
-$38.63M
Net income
-$53.36M
Gross margin
-2.2%
Net margin
-788.2%
The company's gross margin has shrunk by 105% YoY but it has surged by 98% QoQ
PRPH's revenue has surged by 102% since the previous quarter but it has dropped by 81% year-on-year
The gross profit has plunged by 101% YoY but it has soared by 97% from the previous quarter
The net income has dropped by 92% since the previous quarter
Growth
What is ProPhase Labs's growth rate over time
Valuation
What is ProPhase Labs stock price valuation
P/E
N/A
P/B
1.04
P/S
0.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.52
The EPS has plunged by 166% YoY and by 69% from the previous quarter
ProPhase Labs's equity has shrunk by 85% YoY and by 81% QoQ
PRPH's price to book (P/B) is 60% lower than its 5-year quarterly average of 2.5 and 50% lower than its last 4 quarters average of 2.0
PRPH's revenue has surged by 102% since the previous quarter but it has dropped by 81% year-on-year
The P/S is 88% lower than the last 4 quarters average of 7.8 and 72% lower than the 5-year quarterly average of 3.4
Efficiency
How efficient is ProPhase Labs business performance
PRPH's return on equity has dropped by 152% since the previous quarter
The return on invested capital has dropped by 112% year-on-year and by 36% since the previous quarter
ProPhase Labs's return on assets has shrunk by 109% QoQ
The ROS has increased by 40% from the previous quarter
Dividends
What is PRPH's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did ProPhase Labs financials performed over time
PRPH's total assets is 13% greater than its total liabilities
The company's quick ratio has shrunk by 66% YoY and by 43% QoQ
ProPhase Labs's current ratio has plunged by 58% YoY and by 35% from the previous quarter
ProPhase Labs's equity has shrunk by 85% YoY and by 81% QoQ
The debt has grown by 33% YoY but it has contracted by 17% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.